The first national workshop on thalassemia - a genetic blood disease - and the second Pan-Asian Conference on Haemoglobinopathies and Rare Anaemias are taking place in Hanoi.
The first national workshop on thalassemia - a genetic blood disease - and the second Pan-Asian Conference on Haemoglobinopathies and Rare Anaemias are taking place in Hanoi.
Nearly 800 domestic and international scientists are participating in the events on September 24 and 25, hosted by the National Institute of Haematology and Blood Transfusion ( NIHBT) , the Vietnam Thalassemia Association (VNTA) and the Thalassaemia International Federation (TIF).
More than 50 scientific reports are being presented at the domestic event while 40 others will be updated at the regional function, highlighting blood disorder diseases; thalassemia detection, treatment and prevention; and patient care programmes.
Director of the NIHBT and President of the VNTA Nguyen Anh Tri highlighted haemoglobinopathies and rare anaemias are some of the most common genetic diseases in the world, including thalassemia.
The disease affects up to 71 percent of nations globally, he said, adding that around 7 percent of pregnant women are carriers of the thalassemina gene and some 1.1 percent of married couples face the risk passing on the disease to their children.
It is found most commonly in the Mediterranean, the Middle East and the Asia-Pacific region, including Vietnam.
Globally, about 90 million people are carriers of the thalassemia gene (making up 1.5 percent of the world’s population), half of whom are from Southeast Asia.
Each year, the world sees around 60,000-70,000 children born with the disease, Tri said.
In Vietnam, it is estimated more than 10 million citizens are carrying the gene, with the highest rate in some ethnic groups such as Stieng (63.9 percent), Ede (32.2 percent), Khmer (28.2 percent) and Muong (21.74 percent).
ꦺ About 20,000 people have the disease and need treatment nationally, he said, adding that close to 2,000 children are born with the disease every year.
Thalassemia is a form of anaemia, a genetic blood disease a child can inherit if one or both of his/her parents carry the mutant gene. The risk is higher if both parents have it.
The disease is not always symptomatic, but can be identified through testing. It is caused by variant or missing genes that affect how the body makes haemoglobin, the protein in red blood cells that carries oxygen.-VNA
A project aiming to reduce the number of Thalassemia sufferers carried out in the northern mountainous province of Hoa Binh in 2009-2014 has proven effective, helping raise public awareness of the disease.
Stores of blood-type-A at the Hanoi-based National Institute of Haematology and Blood Transfusion are almost exhausted with only 160 units of 250ml left.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Illustrative image (Source: VNA)
